IBM vs PACB · P/E 25, rev $17.16B vs rev $76.2M
International Business Machines (IBM) versus Pacific Biosciences of California (PACB) — a side-by-side from cached financials, not a winner call.
International Business Machines (IBM) is a information technology services company listed on US. It is led by Arvind Krishna.
Pacific Biosciences of California (PACB) is a medical devices company listed on US.
Latest reported IBM revenue for 2026-06-30 was $17.16B. Net income was $2.17B. Revenue was up 7.8% from 2026-03-31 to 2026-06-30. IBM currently screens at market cap $267.72B and trailing P/E 25.2.
Latest reported PACB revenue for 2026-06-30 was $76.2M. Net income was -$53.0M. PACB currently screens at market cap $387.1M.
IBM currently screens at market cap $267.72B and trailing P/E 25.2. PACB currently screens at market cap $387.1M.
Not investment advice. Open the IBM and PACB stock pages for the full models.
Not investment advice.